Kurepen Dry Syrup is a combination antibiotic formulation containing Amoxycillin 200 mg and Clavulanic Acid 28.5 mg per 5 ml of reconstituted suspension. Amoxycillin, a broad-spectrum penicillin antibiotic, acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxycillin from enzymatic degradation by beta-lactamase-producing bacteria, thereby extending its antimicrobial spectrum. Kurepen Dry Syrup is indicated for the treatment of various bacterial infections including respiratory tract infections, otitis media, sinusitis, urinary tract infections, skin and soft tissue infections, and dental infections caused by susceptible organisms. The dry syrup formulation is particularly suitable for pediatric patients and those with swallowing difficulties, ensuring accurate dosing and improved compliance. It is important to reconstitute the powder with the specified volume of water before administration and to complete the full course of therapy to prevent resistance development. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting. Hypersensitivity reactions, though rare, may occur in penicillin-sensitive individuals. Kurepen Dry Syrup should be used cautiously in patients with a history of allergy to beta-lactam antibiotics and renal impairment. Always consult a healthcare professional before initiating therapy.